Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Paul Chinn"'
Autor:
Benjamin Bonavida, Ali R. Jazirehi, Kandasamy Hariharan, Nabil Hanna, Paul Chinn, Cesar R. González-Bonilla, Rogelio Hernandez-Pando, Bernardo Martinez-Miguel, Melisa Martinez-Paniagua, Sara Huerta-Yepez, Mario I. Vega
Purpose: Rituximab [chimeric anti-CD20 monoclonal antibody], alone or combined with chemotherapy, is used in the treatment of non–Hodgkin's lymphoma (NHL). Rituximab binds to CD20 and inhibits intracellular survival/growth pathways leading to chemo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::843096e1ec543755a15e6df26b730d79
https://doi.org/10.1158/1078-0432.c.6517765
https://doi.org/10.1158/1078-0432.c.6517765
Autor:
Benjamin Bonavida, Ali R. Jazirehi, Kandasamy Hariharan, Nabil Hanna, Paul Chinn, Cesar R. González-Bonilla, Rogelio Hernandez-Pando, Bernardo Martinez-Miguel, Melisa Martinez-Paniagua, Sara Huerta-Yepez, Mario I. Vega
Supplementary Data from Rituximab-Mediated Cell Signaling and Chemo/Immuno-sensitization of Drug-Resistant B-NHL Is Independent of Its Fc Functions
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1213ac1010b5e7a3bb42993e5ae6b89c
https://doi.org/10.1158/1078-0432.22440436
https://doi.org/10.1158/1078-0432.22440436
Autor:
Ron A. Morena, Nabil Hanna, Braslawsky Gary R, Syed V. S. Kashmiri, Jeffrey Schlom, Paul Chinn, Denise A. Santoro, Timothy Kazules
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 21:106-116
The primary limitation of IgG antibodies for radioimmunotherapy of solid tumors is their prolonged serum half-life, leading to dose-limiting bone marrow toxicity at doses providing inadequate radiation to the tumor. A humanized C(H)2 domain-deleted v
Autor:
Soulaima Chamat, Nakamura Takehiko, Reff Mitchell E, Peter Brams, William S. Shestowsky, Agnes Chen, Xianjun Cao, William S. Kloetzer, Kandasamy Hariharan, Yan Ping Li, Paul Chinn, Michael J. Labarre, Ron A. Morena
Publikováno v:
International Journal of Immunopharmacology. 22:131-141
CD23, the low affinity receptor for IgE (FcvarepsilonRII), is involved in regulation of IgE synthesis by B-lymphocytes. Five monoclonal antibodies to human CD23 were generated from cynomolgus macaques immunized with purified soluble CD23 (sCD23). Fou
Autor:
Karen S. Chambers, Nabil Hanna, Roland A. Newman, Kristin Carner, Paul Chinn, John E Leonard, Ron Raab, Darrell R Anderson, Reff Mitchell E
Publikováno v:
Blood. 83:435-445
Murine monoclonal antibody 2B8 specifically recognizes the CD20 phosphoprotein expressed on the surface of normal B lymphocytes and B- cell lymphomas. The light- and heavy-chain variable regions of 2B8 were cloned, after amplification by the polymera
Autor:
Rogelio Hernández-Pando, Mario I. Vega, Melisa Martinez-Paniagua, Sara Huerta-Yepez, Benjamin Bonavida, Ali R. Jazirehi, César González-Bonilla, Paul Chinn, Kandasamy Hariharan, Nabil Hanna, Bernardo Martinez-Miguel
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 15(21)
Purpose: Rituximab [chimeric anti-CD20 monoclonal antibody], alone or combined with chemotherapy, is used in the treatment of non–Hodgkin's lymphoma (NHL). Rituximab binds to CD20 and inhibits intracellular survival/growth pathways leading to chemo
Autor:
Paul Chinn, Barnett Richard Spence, Scott Glaser, Daniel Perret, Ron A. Morena, Reff Mitchell E, Karen Hathaway, Jennifer Hopp, Ina E. Hughes, Tim Kazules
Publikováno v:
Journal of Immunotherapy. 27:S53-S54
Publikováno v:
Blood. 104:3404-3404
Rituximab (chimeric anti-CD20 mAb) is currently being used in the therapy of Non-Hodgkin’s B-cell Lymphoma (NHL). It has also been reported that the combination of rituximab and chemotherapy is effective in patients with NHL. Several proposed mecha
Autor:
C.A. White, Nalini Janakiraman, John Gutheil, G. A. Wiseman, T. E. Witzig, Andrew Raubitschek, William L. Dunn, Paul Chinn, Christos Emmanouilides, Antonio J. Grillo-Lopez, Russell J. Schilder, Leo I. Gordon
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 42:130
Autor:
Sherry Fowler, Michael L. Goris, Nimisha Deb, Thomas A. Davis, Ron A. Morena, Shoucheng Ning, Kirk Trisler, Mark Becker, Carol Marquez, Ronald Levy, TM Liles, Paul Chinn, Brian Dallaire, Susan J. Knox, Antonio J. Grillo-Lopez
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 32:215